- $542.79m
- $430.54m
- $200.93m
Annual cashflow statement for SI-Bone, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -56.6 | -61.3 | -43.3 | -30.9 | -18.9 |
| Depreciation | |||||
| Non-Cash Items | 20.7 | 23.8 | 24 | 24.2 | 26.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.76 | -7.64 | -4.83 | -10.1 | -14.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -39.5 | -41.7 | -18.7 | -12.4 | -0.675 |
| Capital Expenditures | -6.39 | -9.51 | -7.8 | -10.5 | -8.41 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 58 | 6.69 | -52 | 23.1 | 12.6 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 51.6 | -2.81 | -59.8 | 12.6 | 4.16 |
| Financing Cash Flow Items | -0.619 | 0 | -0.04 | -0.046 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.71 | 2.2 | 90.9 | 1.96 | 3.38 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.84 | -42.7 | 12.6 | 1.68 | 7.29 |